Metastatic Pancreatic Cancer With George P. Kim, MD, and Eileen M. O'Reilly, MD
EP. 1: Eileen M. O'Reilly, MD: How the Treatment Course Aligns With New NCCN Guidelines
Watch
EP. 2: George P. Kim, MD: How the Treatment Course Aligns With New NCCN Guidelines
EP. 3: Eileen M. O'Reilly, MD: The Nab-Paclitaxel/Gemcitabine Regimen in Frontline Standard of Care
EP. 4: George P. Kim, MD: The Nab-Paclitaxel/Gemcitabine Regimen in Frontline Standard of Care
EP. 5: Eileen M. O'Reilly, MD: The Significance of Second-Line Therapy in Pancreatic Cancer
EP. 6: George P. Kim, MD: The Significance of Second-Line Therapy in Pancreatic Cancer
EP. 7: Eileen M. O'Reilly, MD: The Evolution of Therapy Sequencing Strategies in Pancreatic Cancer
EP. 8: George P. Kim, MD: The Evolution of Therapy Sequencing Strategies in Pancreatic Cancer
EP. 9: Eileen M. O'Reilly, MD: Diagnosing Patients With Pancreatic Cancer at an Earlier Stage
EP. 10: George P. Kim, MD: Diagnosing Patients With Pancreatic Cancer at an Earlier Stage
